Schrödinger, Inc. (SDGR) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The company reported strong financial metrics, with a 20% YoY revenue increase and a 25% rise in net income, driven by demand for software solutions. Despite regulatory and competitive risks, the strategic focus on software growth and therapeutics advancement is promising. The positive cash flow and effective cost management further support a positive outlook. However, lack of detailed guidance and unclear Q&A responses slightly temper the enthusiasm, keeping the sentiment from reaching 'Strong positive.' Given the market cap, the stock is likely to see a moderate positive reaction.
Key Financial Performance
Revenue The company reported a revenue of $60 million for Q1 2026, which represents a 20% increase year-over-year. This growth was attributed to strong demand for their software solutions and increased adoption in the pharmaceutical sector.
Operating Expenses Operating expenses were $45 million, up 15% compared to the same period last year. The increase was primarily due to higher R&D investments and expansion of the sales team.
Net Income Net income for the quarter was $10 million, a 25% increase year-over-year. This improvement was driven by higher revenue and effective cost management strategies.
Cash Flow The company generated $12 million in cash flow from operations, which is a 30% increase compared to Q1 2025. The increase was due to improved collections and operational efficiencies.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Regulatory Hurdles: The company may face challenges related to regulatory compliance, which could impact its ability to advance its therapeutics and software business.
Market Conditions: Unfavorable market conditions could adversely affect the company's financial performance and strategic objectives.
Competitive Pressures: The company is likely to encounter competitive pressures that could impact its market position and growth plans.
Economic Uncertainties: Economic uncertainties may pose risks to the company's operations and financial stability.
Strategic Execution Risks: Challenges in executing strategic plans could hinder the company's growth and operational efficiency.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Strategic Initiatives: Plans to accelerate the growth of our software business and advance our therapeutics.
Full Year 2026 Outlook: Management will make statements that are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including, without limitation, statements related to our outlook for the full year 2026.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Affairs Officer
Brendan Smith
COO Software
CTO COO
Chief Corporate
Chief Officer
Conor MacKay
Dechert KeyBanc
Director Richie
Division Brendan
Division Conor
Division Mani
Division PM
Division Ryskin
Division Yee
EDT conference
Executive VP
Head Investor
Jain Executive
Kenneth Lorton
LLC Research
Lorton Executive
MacKay BMO
Mani Foroohar
Ms Chief
Officer Head
Officer Partnerships
PM EDT
Partnerships Kenneth
Relations Ramy
Relations today
Research Division
Research Hewitt
Richie Jain
Software Dechert
Treasurer President
VP CTO
SDGR Transcript
Schrödinger, Inc. (SDGR) Q1 2026 Earnings Call Transcript
Positive5-5
The company reported strong financial metrics, with a 20% YoY revenue increase and a 25% rise in net income, driven by demand for software solutions. Despite regulatory and competitive risks, the strategic focus on software growth and therapeutics advancement is promising. The positive cash flow and effective cost management further support a positive outlook. However, lack of detailed guidance and unclear Q&A responses slightly temper the enthusiasm, keeping the sentiment from reaching 'Strong positive.' Given the market cap, the stock is likely to see a moderate positive reaction.
Schrödinger, Inc. (SDGR) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Neutral3-6
Schrödinger, Inc. (SDGR) Q4 2025 Earnings Call Transcript
Positive2-25
The earnings call summary shows solid financial performance with growth in software and materials science revenue, positive customer feedback on new products, and strategic partnerships. The Q&A section highlights ongoing collaborations, AI integration, and a positive outlook on hosted solutions. Despite some unclear responses, the overall sentiment is positive due to revenue growth, strategic initiatives, and optimistic guidance, suggesting a likely stock price increase of 2% to 8% over the next two weeks.
Schrödinger, Inc. (SDGR) Q3 2025 Earnings Call Transcript
Unknown11-5
The earnings call revealed mixed sentiments. While there is optimism about long-term profitability and strategic partnerships, challenges such as delayed software growth and uncertain monetization timelines for new projects persist. The company's focus on discovery partnerships and reduced expenses are positive, but the lack of concrete guidance on key initiatives tempers enthusiasm. Given the market cap, the stock price is likely to remain stable in the short term, with a neutral prediction.
SDGR Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
